TSXV:APC.H - Post by User
Comment by
Goldnboy1on Feb 10, 2021 6:35am
102 Views
Post# 32522178
RE:Will these guys miss the boat
RE:Will these guys miss the boat This company has no interest in jumping into a fad vaccine. They totally considered it. But the fine print in the government rules did not suit them.
So a decision was made to de prioritize this pursuit.
Also at the time it was stated the company felt it was making necessary breakthroughs that would lead to monetization of their core technology.
$APC.v is a conjugate cancer therapy combination drug. Essentially their therapy when added to pre existing drugs in their market. Reduces the toxicity by 15x.
Similar tech to $TH.t. They just announced advanced trials related to a similar conjugate.
In the end. This is about cancer patients undergoing chemo related treatment. Reducing toxicity. May mean less hair loss, less body aches, less nausea, less overall stress related to treatments. Etc. Just an overall enhancement of the drugs involved.
Best part. Nine drugs own the entire market. 8/9 earn annual sales in excess of $1b.
New trials with expanded cohorts coming. For a company that is broke and in desperate need of funding. Something has got to give.
When they get a licence in the future, it will absolutely send this stock to the moon. Best part. Once one licence signs. Competitors will want to sign.
We will be providing a bio best in class upgrade to their drugs. Can't see how that doesn't cause a bit of a frenzy. If this can all come to fruition.